Literature DB >> 28709113

Reprogramming cellular functions with engineered membrane proteins.

Caroline Arber1, Melvin Young2, Patrick Barth3.   

Abstract

Taking inspiration from Nature, synthetic biology utilizes and modifies biological components to expand the range of biological functions for engineering new practical devices and therapeutics. While early breakthroughs mainly concerned the design of gene circuits, recent efforts have focused on engineering signaling pathways to reprogram cellular functions. Since signal transduction across cell membranes initiates and controls intracellular signaling, membrane receptors have been targeted by diverse protein engineering approaches despite limited mechanistic understanding of their function. The modular architecture of several receptor families has enabled the empirical construction of chimeric receptors combining domains from distinct native receptors which have found successful immunotherapeutic applications. Meanwhile, progress in membrane protein structure determination, computational modeling and rational design promise to foster the engineering of a broader range of membrane receptor functions. Marrying empirical and rational membrane protein engineering approaches should enable the reprogramming of cells with widely diverse fine-tuned functions.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28709113      PMCID: PMC5621657          DOI: 10.1016/j.copbio.2017.06.009

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  62 in total

1.  Evolutionarily conserved pathways of energetic connectivity in protein families.

Authors:  S W Lockless; R Ranganathan
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

2.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.

Authors:  Blaine N Armbruster; Xiang Li; Mark H Pausch; Stefan Herlitze; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

Review 3.  Specificity in two-component signal transduction pathways.

Authors:  Michael T Laub; Mark Goulian
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

4.  Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.

Authors:  R H Oakley; S A Laporte; J A Holt; M G Caron; L S Barak
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 5.  Optical control of neuronal activity.

Authors:  Stephanie Szobota; Ehud Y Isacoff
Journal:  Annu Rev Biophys       Date:  2010       Impact factor: 12.981

6.  A chemical switch for inhibitor-sensitive alleles of any protein kinase.

Authors:  A C Bishop; J A Ubersax; D T Petsch; D P Matheos; N S Gray; J Blethrow; E Shimizu; J Z Tsien; P G Schultz; M D Rose; J L Wood; D O Morgan; K M Shokat
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

Review 7.  Engineering GPCR signaling pathways with RASSLs.

Authors:  Bruce R Conklin; Edward C Hsiao; Sylvie Claeysen; Aline Dumuis; Supriya Srinivasan; John R Forsayeth; Jean-Marc Guettier; W C Chang; Ying Pei; Ken D McCarthy; Robert A Nissenson; Jürgen Wess; Joël Bockaert; Bryan L Roth
Journal:  Nat Methods       Date:  2008-08       Impact factor: 28.547

8.  New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).

Authors:  Vindhya Nawaratne; Katie Leach; Nur Suratman; Richard E Loiacono; Christian C Felder; Blaine N Armbruster; Bryan L Roth; Patrick M Sexton; Arthur Christopoulos
Journal:  Mol Pharmacol       Date:  2008-07-15       Impact factor: 4.436

9.  A chemical-genetic approach to study G protein regulation of beta cell function in vivo.

Authors:  Jean-Marc Guettier; Dinesh Gautam; Marco Scarselli; Inigo Ruiz de Azua; Jian Hua Li; Erica Rosemond; Xiaochao Ma; Frank J Gonzalez; Blaine N Armbruster; Huiyan Lu; Bryan L Roth; Jürgen Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

10.  Engineered interleukin-2 antagonists for the inhibition of regulatory T cells.

Authors:  David V Liu; Lisa M Maier; David A Hafler; K Dane Wittrup
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

View more
  4 in total

1.  Computational design of orthogonal membrane receptor-effector switches for rewiring signaling pathways.

Authors:  M Young; T Dahoun; B Sokrat; C Arber; K M Chen; M Bouvier; P Barth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 2.  Synthetic development: building mammalian multicellular structures with artificial genetic programs.

Authors:  Marco Santorelli; Calvin Lam; Leonardo Morsut
Journal:  Curr Opin Biotechnol       Date:  2019-05-23       Impact factor: 9.740

3.  Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.

Authors:  Theodore L Roth; P Jonathan Li; Franziska Blaeschke; Jasper F Nies; Ryan Apathy; Cody Mowery; Ruby Yu; Michelle L T Nguyen; Youjin Lee; Anna Truong; Joseph Hiatt; David Wu; David N Nguyen; Daniel Goodman; Jeffrey A Bluestone; Chun Jimmie Ye; Kole Roybal; Eric Shifrut; Alexander Marson
Journal:  Cell       Date:  2020-04-16       Impact factor: 41.582

Review 4.  Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.

Authors:  Jan A Rath; Caroline Arber
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.